CurrentHighmark Blueshield NenyPolicy N/A

Diabetic testing supplies prior authorization form

A prior authorization/coverage request form for diabetic blood glucose testing supplies used to document clinical information, product requested, and reviewer requirements for Highmark Blue Shield regions. It collects patient, provider, clinical criteria (diabetes status, pregnancy, insulin use, hypoglycemia history, vision/manual dexterity impairment), and product history for authorization determination.

Policy Summary

PayerHighmark Blueshield Neny

PolicyDiabetic testing supplies prior authorization form

Policy CodePolicy N/A

Change TypeNo material change

Effective Date

Next Review Date

Key ActionInclude chart notes to support history of poorly controlled diabetes, hypoglycemic events, insulin pump use, prior product failures, or other clinical assertions when indicated.

SourceLink

POLICY UPDATE CHANGES

No material clinical/coverage changes identified.

30/90Requested supply day options (days)

6 monthsRequired practitioner follow-up interval

N/ACovered Indications

Policy overview

This prior authorization form is used by Highmark Blue Shield regions to document and collect the information needed to determine medical necessity for diabetic blood glucose testing supplies. It gathers member identifiers and contact details, treating provider information and signature, the requested product and supply duration (including 30 or 90 day options), diagnosis/ICD-10 code(s), and product history to support an authorization decision.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.